Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 4Leukemia, Myeloid, Acute 3Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Rhabdoid Tumor 1Recurrence 1Primary Myelofibrosis 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Graft vs Host Disease 1Glioma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Congenital Abnormalities 1Choroid Plexus Carcinoma 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 3thymoglobulin 1gallium Ga 68 dotatate 1fludarabine phosphate 1Valproic Acid 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Gadolinium DTPA 1Etoposide 1Biopsy 1Antilymphocyte Serum 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive × Antilymphocyte Serum × Clear all
NCT04521946 2024-10-26

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

M.D. Anderson Cancer Center

Phase 1 Withdrawn
CNS

Choroid Plexus Carcinoma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡